Warning letter
PRL Inc: warning letter of Jun 6, 2019
FDA warning letter 568952 · Division of Human and Animal Food Operations East V
Key facts
| Reference number | 568952 |
|---|---|
| Company | PRL Inc |
| Subject | CGMP/Dietary Supplement/Adulterated/Misbranded |
| Issue date | Jun 6, 2019 |
| Posted date | Jun 18, 2019 |
| Issuing office | Division of Human and Animal Food Operations East V |
| Product type | Food/Cosmetics |
| CFR sections cited | 101.4, 101.36, 111, 111.73, 111.75, 111.210, 111.260, 101.9, 111.27(b), 111.27(b)(1), 111.27(b)(2), 111.27(b)(3) and 22 more |
| Inspection city | Lobelville |
| Inspection ZIP | 37097 |
| Inspection start date | Oct 16, 2018 |
| Letter on fda.gov | fda.gov |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: